Division of Experimental Oncology
You are here: Division of Experimental Oncology > Group Rüegg > Publications > 1989-1994

Publications 1989-1994

1989 - 1994

C. Rüegg, R. Chiquet-Ehrismann, and S. Alkan (1989). Tenascin, an extracellular matrix protein, exerts immunomodulatory activities. Proc. Natl. Acad. Sci. USA, 86:7437-7441

M. Stoeck, C. Rüegg, S. Miescher, S. Carrel, D. Cox, V. von Fliedner, S. Alkan (1990). Comparison of the immunosuppressive properties of milk growth factor and transforming growth factor beta 1 and 2. J. Immunol., 134:3258-3265

D.J. Erle, D. Sheppard, J. Breuss, C. Rüegg, and R. Pytela (1991). Novel integrin alpha and beta subunit cDNA identified in airway epithelial cells and lung leukocytes using the polymerase chain reaction. Am. J. Respir. Cell. Mol. Biol., 5:170-177

D.J. Erle, C. Rüegg, D. Sheppard, and R. Pytela (1991). Complete amino acid sequence of an integrin beta subunit (beta 7). identified in leukocytes. J. Biol. Chem., 266:11009-16
C. Rüegg, A.A. Postigo, E.E. Sikorski, E.C. Butcher, R. Pytela and D.J. Erle (1992).

Role of integrin alpha4beta7/alpha4betaP in lymphocyte adherence to fibronectin and VCAM 1 and in homotypic cell clustering. J. Cell Biol., 117:179-189

A.M. Boylan, C. Rüegg, K.J. Kim, C.A. Hebert, R. Pytela, D. Sheppard, I.M. Goldstein, and V.C. Broaddus (1992). Evidence of a role for mesothelial-cell derived interleukin-8 in the pathogenesis of asbestos induced pleurisy in rabbits. J. Clin. Invest., 89:1257-1267

C. Rüegg, R. Pytela, D. J. Erle (1993). Characterization of the leukocyte integrin subunit beta 7. Chest, 103:86S.

E. Palmer, C. Rüegg, R. Ferrando, R. Pytela, and D. Sheppard (1993). Sequence and tissue distribution of the integrin alpha9 subunit, a novel partner of beta1 that is widely expressed in epithelium and muscle. J. Cell Biol., 123:1289-1297


 inside this site:
Chemin des Boveresses 155 - CH-1066 Epalinges  - Switzerland  -  Tel. +41 21 69258 42  -  Fax +41 21 65269 33
Swiss University